Exosens
EXENS.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | – | – | – | – |
| - Cash | $117 | $15 | $29 | $16 |
| + Debt | $256 | $304 | $246 | $221 |
| Enterprise Value | – | – | – | – |
| Revenue | $394 | $319 | $201 | $166 |
| % Growth | 23.6% | 58.8% | 20.8% | – |
| Gross Profit | $226 | $177 | $114 | $100 |
| % Margin | 57.2% | 55.5% | 56.8% | 60.2% |
| EBITDA | $115 | $84 | $51 | -$101 |
| % Margin | 29.2% | 26.3% | 25.5% | -60.9% |
| Net Income | $31 | $17 | $11 | -$149 |
| % Margin | 7.8% | 5.4% | 5.6% | -89.6% |
| EPS Diluted | 0.6 | 0.56 | 0.37 | -4.9 |
| % Growth | 7.1% | 51.4% | 107.6% | – |
| Operating Cash Flow | $96 | $50 | $47 | $43 |
| Capital Expenditures | -$41 | -$31 | -$22 | -$20 |
| Free Cash Flow | $96 | $20 | $26 | $23 |